These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 21835918)

  • 21. Altered cellular localisation and expression, together with unconventional protein trafficking, of prion protein, PrP
    Hiller H; Yang C; Beachy DE; Kusmartseva I; Candelario-Jalil E; Posgai AL; Nick HS; Schatz D; Atkinson MA; Wasserfall CH
    Diabetologia; 2021 Oct; 64(10):2279-2291. PubMed ID: 34274990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders.
    Mishra RS; Bose S; Gu Y; Li R; Singh N
    J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggregation and amyloid fibril formation induced by chemical dimerization of recombinant prion protein in physiological-like conditions.
    Roostaee A; Côté S; Roucou X
    J Biol Chem; 2009 Nov; 284(45):30907-16. PubMed ID: 19710507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endoplasmic reticulum stress, PrP trafficking, and neurodegeneration.
    Soto C
    Dev Cell; 2008 Sep; 15(3):339-341. PubMed ID: 18804431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manganese upregulates cellular prion protein and contributes to altered stabilization and proteolysis: relevance to role of metals in pathogenesis of prion disease.
    Choi CJ; Anantharam V; Martin DP; Nicholson EM; Richt JA; Kanthasamy A; Kanthasamy AG
    Toxicol Sci; 2010 Jun; 115(2):535-46. PubMed ID: 20176619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolving views in prion glycosylation: functional and pathological implications.
    Ermonval M; Mouillet-Richard S; Codogno P; Kellermann O; Botti J
    Biochimie; 2003; 85(1-2):33-45. PubMed ID: 12765773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prions impair bioaminergic functions through serotonin- or catecholamine-derived neurotoxins in neuronal cells.
    Mouillet-Richard S; Nishida N; Pradines E; Laude H; Schneider B; Féraudet C; Grassi J; Launay JM; Lehmann S; Kellermann O
    J Biol Chem; 2008 Aug; 283(35):23782-90. PubMed ID: 18617522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decoding the function of the N-terminal tail of the cellular prion protein to inspire novel therapeutic avenues for neurodegenerative diseases.
    Iraci N; Stincardini C; Barreca ML; Biasini E
    Virus Res; 2015 Sep; 207():62-8. PubMed ID: 25456402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
    Bate C; Williams A
    J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytosolic prion protein (PrP) is not toxic in N2a cells and primary neurons expressing pathogenic PrP mutations.
    Fioriti L; Dossena S; Stewart LR; Stewart RS; Harris DA; Forloni G; Chiesa R
    J Biol Chem; 2005 Mar; 280(12):11320-8. PubMed ID: 15632159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
    McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
    Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant PrP is delayed in its exit from the endoplasmic reticulum, but neither wild-type nor mutant PrP undergoes retrotranslocation prior to proteasomal degradation.
    Drisaldi B; Stewart RS; Adles C; Stewart LR; Quaglio E; Biasini E; Fioriti L; Chiesa R; Harris DA
    J Biol Chem; 2003 Jun; 278(24):21732-43. PubMed ID: 12663673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteasomes and ubiquitin are involved in the turnover of the wild-type prion protein.
    Yedidia Y; Horonchik L; Tzaban S; Yanai A; Taraboulos A
    EMBO J; 2001 Oct; 20(19):5383-91. PubMed ID: 11574470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor.
    Kiachopoulos S; Bracher A; Winklhofer KF; Tatzelt J
    J Biol Chem; 2005 Mar; 280(10):9320-9. PubMed ID: 15591591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
    Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
    J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70).
    Mays CE; Armijo E; Morales R; Kramm C; Flores A; Tiwari A; Bian J; Telling GC; Pandita TK; Hunt CR; Soto C
    J Biol Chem; 2019 Sep; 294(37):13619-13628. PubMed ID: 31320473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of infectivity from seeding ability in prions with alternate docking mechanism.
    Miller MB; Geoghegan JC; Supattapone S
    PLoS Pathog; 2011 Jul; 7(7):e1002128. PubMed ID: 21779169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.
    Meier P; Genoud N; Prinz M; Maissen M; Rülicke T; Zurbriggen A; Raeber AJ; Aguzzi A
    Cell; 2003 Apr; 113(1):49-60. PubMed ID: 12679034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.